Nav: Home

Safe to breastfeed while on bipolar meds? Jury's still out

June 10, 2019

  • Prior research on lithium's effects on breastfeeding are sparse, poorly designed
  • Study author: 'It's 2019, and we still don't have the evidence to back any of this up'
  • Discontinuing lithium to breastfeed could lead to greater risks for mom, baby
  • Until more research is done, mothers, babies should be reviewed case by case for lithium continuation
CHICAGO --- Women taking lithium to treat their bipolar disorder frequently ask if breastfeeding while on the medication will harm their babies. Those fears are largely rooted in sparse studies that have not addressed critical factors, reports a new Northwestern Medicine systematic review.

The review will be published June 10 in the International Review of Psychiatry.

The mood stabilizer lithium is the gold standard of care for treating bipolar disorder, which affects an estimated 22 million women worldwide. It is effective at preventing manic episodes and postpartum psychosis but some experts advise against taking lithium while breastfeeding because of concerns that it will transfer to the breast milk and potentially be toxic to the baby.

Prior to 2000, research on the effects of lithium exposure through breastmilk were retrospective and lacked standardization, such as not including control groups and not considering the health of the mother or her infant or the other medications the mother was taking, the review found. Studies after 2000 were better designed and suggest that lithium is low risk during breastfeeding. Still, more research is needed, the authors said.

"This is a highly controversial topic, and expert recommendations vary, but the truth is it's 2019, and we still don't have the evidence to back up any of the fears about lithium use and breastfeeding," said senior author Dr. Crystal Clark, assistant professor of psychiatry and behavioral sciences and obstetrics and gynecology at Northwestern University Feinberg School of Medicine and a practicing Northwestern Medicine psychiatrist.

The continuation of lithium, like many medications, must be considered on a case-by-case basis and personalized to the individual woman and her infant, the authors reported.

"There are few absolutes when it comes to managing illness while breastfeeding," Clark said. "It's not one size fits all."

Until more research is done, Clark and her co-authors suggest informing patients of possible risks of lithium exposure, such as restlessness, lethargy or feeding problems.

Women typically experience bipolar disorder throughout their childbearing years. Pregnancy and the postpartum period are especially vulnerable times for women with the illness, leading to an increased risk of a recurring episode or postpartum psychosis. Untreated bipolar disorder is associated with poor birth outcomes, such as preterm birth and babies who are small for their gestational age, as well as an increased risk for suicide, which is a leading cause of maternal death.

While the risks of breastfeeding on lithium are still largely unknown, the risks of interrupting lithium treatment are well established and could impact a mother's ability to care for her child or bond with her baby during a critical time, Clark said.

"I don't see the same breastfeeding fear with women taking medications for other illnesses such as seizure disorders," Clark said, referring to the many medications that have not been well studied but are not discouraged for breastfeeding. "There is some stigma related to mental illness that deters physicians from considering it as a vital treatment for the health of their postpartum mothers with mental illness."

For women taking lithium, the benefits of breastfeeding may justify the risks of breastmilk exposure, Clark said. In future studies, she plans to examine the amount of lithium in breastmilk as well as how much lithium is ingested by the breastfed infants and the effects on early childhood development.

The review authors screened 441 studies for eligibility, reviewed 230 that met their inclusion criteria and chose 12, which included a total of 37 patient case studies.
-end-
This study was supported by the National Institute of Child Health and Human Development grant K23 (1K23HD087529-01A1). Other Northwestern authors include Dr. Katherine Wisner, Rebecca Newmark, Dr. Mariana Isaac and Jody Ciolino.

Northwestern University

Related Preterm Birth Articles:

WVU biostatistician studies link between microbiome and preterm birth
Pregnant African American women are more likely than white women to give birth prematurely, but they're underrepresented in studies of preterm birth rates.
3D-printed device detects biomarkers of preterm birth
Preterm birth (PTB) -- defined as birth before the 37th week of gestation -- is the leading complication of pregnancy.
Association of quitting smoking during pregnancy, risk of preterm birth
This study of more than 25 million pregnant women reports on rates of smoking cessation at the start of and during pregnancy and also examines the association of quitting cigarette smoking and the risk of preterm birth.
Blood test developed to predict spontaneous preterm birth
Results from a multicenter study show that five circulating microparticle proteins found in first-trimester blood samples may provide important clues about risk of spontaneous preterm birth.
Scientists gain new insight on triggers for preterm birth
A group of scientists led by Ramkumar Menon at The University of Texas Medical Branch at Galveston have gained new insight on a poorly-understood key player in the timing of labor and delivery.
More Preterm Birth News and Preterm Birth Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...